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ABSTRACT 
RISK FACTORS ASSOCIATED WITH THE DEVELOPMENT OF PREECLAMPSIA 
IN ADOLESCENT PREGNANCY. Amy L. Winkelsteim, Sara J. Marder and Chaur-Dong 
Hsu. Department of Obstetrics/Gynecology, Yale University, School of Medicine, New Haven, 
CT. 
This study aimed to identify risk factors associated with the development of preeclampsia during 
adolescent pregnancy. We performed a retrospective cohort study of 435 pregnant adolescent women, age 
< 18 years, between January 1, 1994 and April 26, 1997. Demographic data, gynecologic age (GA) (years 
between menarche and conception), chronologic age (CA), prepregnancy body mass index (PBM1), weight 
gain, medical, surgical, obstetric, gynecologic, social and family history were abstracted from records. 
Preeclampsia (PE) was defined as hypertensive proteinuria. PBM1 was defined as weight/height (kg/m2). 
Data were analyzed using contingency table, simple and multiple logistic regression analyses. Data were 
expressed as odds ratios with 95% confidence intervals (OR, 95% Cl). Fifty-six out of 435 pregnant 
adolescent women (12.9%) developed PE. Simple logistic regression analysis revealed that GA (OR:Q.82, 
95% Cl: 0.69-0.96, p=0.02) and CA (OR:0.81, 95% Cl: 0.67-0.99, p=0.04) were negatively correlated with 
PE. PBMI (OR: 1.11,95% Cl: 1.05-1.17, p=0.0003), prepregnancy weight (OR: 1.01, 95% Cl: 1.01-1.02, 
p=0.0008), total weight gain (OR: 1.046, 95% Cl: 1.02-1.07, p=0.0001), weight gain per week (OR: 2.40, 
95% CE1.42-4.06, p=0.001) and urinary tract infection (OR: 2.00, 95% Cl:1.03-3.89,p=0.04) were 
positively correlated with PE. When GA< 4 years (OR: 2.12, 95%CI: 1.20-3.75, p=0.01), CA< 17 years 
(OR: 1.99, 95% Cl: 1.10-3.62, p=0.02) or PBMI >30 obese adolescents were at significantly increased risk 
for PE. After adjustment for significant factors, the risk for PE with GA <4 years (OR:2.22, 95% 0:1.121- 
4.407, p=0.02), CA< 17 years ( OR:2.85, 95%CI: 1.374-5.889, p=0.005), GA <4 years and CA<17 years 
(OR: 3.27, 95% Cl: 1.627-6.552, p=0.0009) or PBMI >30 (OR:4.54, 95% 0:1.46-14.14, p=0.009) 
remained significant. The incidence of PE is higher in pregnant adolescent women than in the general 
population. Low gynecologic and chronologic age and obesity prior to pregnancy are strong risk factors for 
PE in adolescent pregnancy. 
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Introduction: 
Preeclampsia is a leading cause of maternal and neonatal morbidity and mortality 
worldwide (1). Second only to embolism, it is an important cause of maternal death (2). 
Preeclampsia places both the mother and the fetus at increased risk for life threatening 
complications during the antepartum, intrapartum and postpartum periods. The HELLP 
syndrome, (hemolysis, elevated liver enzymes, low platelets), a severe complication of 
preeclampsia, can compromise the health of both the mother and the fetus (3). 
Additionally, preeclampsia is a major cause of preterm delivery, fetal growth restriction 
and perinatal mortality (4). 
Preeclampsia has a reported incidence of 2.6 % to 22.3 % (5,6). This wide range 
in incidence is largely due to differences in definition of preeclampsia and study design, 
e.g. different selection criteria for a study population and differing methods of statistical 
analysis of data. Despite the high incidence of preeclampsia and the potentially severe 
consequences of the disease for both mother and child, the etiology of the disease still 
remains unknown. Although preeclampsia has been studied extensively and many 
hypotheses regarding etiology exist, the specific etiology of the disease and the risk 
factors associated with the disease remain poorly understood. 
Over the years, researchers have explored many different hypotheses regarding 
the pathophysiology of preeclampsia. Currently, five major hypotheses exist: 1) placental 
ischemia, 2) very low-density lipoprotein versus toxicity- preventing activity, 3) immune 
maladaptation, 4) genetic imprinting and finally, 5) a systemic inflammatory response (7, 
8). Six decades ago. Page proposed that the placental component of preeclampsia is 
mediated by reduced placental perfusion (9). Norwitz et al. also hypothesized that the 
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primary event in the development of preeclampsia is a failure of the second wave of 
trophoblast invasion from 16-20 weeks' gestation (10). This failure of trophoblast 
invasion may be responsible for the destruction of the muscularis layer of the spiral 
arteries. Norwitz et al. further assert that as the pregnancy progresses and the metabolic 
demand of the fetoplacental unit increases, the incompletely remodeled spiral arteries are 
unable to accommodate the needed increase in blood flow. This failure of 
accommodation and resulting ischemia may lead to further placental dysfunction and 
what is recognized as preeclampsia clinically (10). Building on this hypothesis, Roberts 
et al. assert that this abnormal placental perfusion results in the production of circulating 
factor(s) that alter endothelial cell function (11). The injured endothelium then activates 
the coagulation cascade resulting in the loss of the ability of the endothelial cells to act as 
a barrier. Consequently, extravasation of extravascular fluid follows, and the endothelial 
cells are unable to buffer the effect of the normally circulating pressors. This final 
breakdown in endothelial cell function leads to what is clinically known as preeclampsia 
(11). Additionally, Krauss et al. showed that elevated soluble intercellular adhesion 
molecule-1 (ICAM-1) and vascular cell adhesion molecule- 1 (VCAM-1) are associated 
with preeclampsia (12). These findings of increased levels of ICAM-1 and VCAM-1 
further support the concept of endothelial cell involvement in the pathogenesis of 
preeclampsia. 
The second major hypothesis currently being evaluated is the very low-density 
lipoprotein versus toxicity-preventing activity theory (7). This hypothesis is built on the 
premise that the body mobilizes nonesterified fatty acids in an attempt to compensate for 
the increased energy demand during pregnancy. It is hypothesized that the mobilization 
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of nonesterified fatty acids reduces the antitoxic activity of albumin to a point at which 
very- low density lipoprotein toxicity is expressed and can then cause damage. 
Another possible basis for the pathophysiology of preeclampsia is the immune 
maladaptation hypothesis (7). This hypothesis suggests that immune maladaptation in the 
body causes abnormal placentation with only shallow invasion of spiral arteries by the 
endovascular cytotrophoblast cells. The trophoblast subsequently fails to induce the 
physiologic dilation and remodeling of spiral arteries (7). Additionally, an increased 
decidual release of cytokines, proteolytic enzymes, and free radicals may mediate 
endothelial cell dysfunction (7, 13). Many examples in the literature support the role of 
the immune system in the etiology of preeclampsia. Dekker suggests that the increased 
incidence of urinary tract infection associated with preeclampsia could be due to this 
immune maladaptation (14). Dekker further proposes that not only urinary tract 
infections but any type of infection may result in an increased production of 
inflammatory products including certain cytokines, free radical species and proteolytic 
enzymes (14). Additionally, Klonoff- Cohen et al. conducted a case- control study 
comparing the contraceptive and reproductive histories of primiparous women with and 
without preeclampsia (15). In this study there was a 2.37 fold increased risk of 
preeclampsia for users of barrier contraceptives that prevent exposure to sperm (95% Cl: 
1.01-5.58) (15). These findings suggest that there is a protective role of repeated sperm 
exposure in decreasing the risk of preeclampsia. This protective role implicates a 
possible role of the immune system in the development of preeclampsia. Robillard et al. 
also show that in primigravidae and multigravidae women the length of sexual 
cohabitation before conception was inversely related to incidence of preeclampsia 
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(pO.OOOl) lending additional support to the immune maladaptation hypothesis (16). 
Smith et al. reported that there is an increased incidence of preeclampsia in pregnancies 
that are the result of donor insemination (relative risk: 1.85, 95% Cl: 1.20-2.85) (17). 
Each of these findings reveals that repeated sperm exposure and subsequent immune 
system desensitization might be protective against the development of preeclampsia. 
The genetic imprinting hypothesis suggests that the development of preeclampsia- 
eclampsia is based on either a single recessive gene or a dominant gene with incomplete 
penetrance (7). After studying the incidences of preeclampsia and eclampsia in 147 
sisters, 248 daughters, 74 granddaughters and 131 daughters-in-law of women with 
preeclampsia, Chesley and Cooper concluded that preeclampsia is likely determined by a 
single recessive gene acting in the affected women instead of in their fetuses (18). They 
determined that the frequency of this gene is 0.25. Additionally, Lie et al found that a 
woman who was pregnant by a partner who has already fathered a preeclamptic 
pregnancy in another woman was at twice the risk of developing preeclampsia in her own 
pregnancy (19). Lie et al further assert that paternal genes, as expressed by the fetus, 
may contribute to the mother's risk of preeclampsia. They also state that it is unlikely 
that purely maternal inheritance, specifically by mitochondrial DNA, is involved in 
preeclampsia (19). 
A fifth main hypothesis, newly presented by Redman et al., suggests that the 
endothelial cell dysfunction and preeclampsia are part of a more generalized intravascular 
inflammatory reaction (8). This study argues that preeclampsia is the result of the 
decompensation of a universal maternal intravascular inflammatory response to 
pregnancy. This decompensation may be the result of either a very strong stimulus or a 
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very strong maternal response to a stimulus. Redman et al consider preeclampsia as the 
extreme end in the range of maternal maladaptation to pregnancy. 
Many other hypotheses exist pertaining to the pathophysiology of preeclampsia. 
After finding that in a group of 101 patients with history of severe early-onset 
preeclampsia 24.7% had a protein S deficiency, 16.0% had activated protein C resistance, 
17.7% had hyperhomocysteinemia and 29.4% had the presence of anticardiolipin 
antibodies, Dekker et al suggested a role of coagulopathies in preeclampsia (20). It 
appears that preeclampsia likely comprises a group of heterogeneous causes of maternal, 
fetal, and placental derivation (21). 
Despite the absence of a clear understanding regarding the etiology of 
preeclampsia, extensive research studies have identified many risk factors for the 
development of the disease. Risk factors include nulliparity, which increases the risk of 
preeclampsia by 3.8 -5.4 times, (16, 22-26), multiple gestations (risk ratio: 4:1)(22, 27), 
advanced maternal age (22, 28), preeclampsia in a previous pregnancy (OR: 10.8, 95% 
Cl: 1.2- 29.1) (25), family history of pregnancy-induced hypertension (risk ratio of 5:1) 
(18), urinary tract infections (OR: 5.3, 95% Cl: 2.9-9.7) (23), high pre-pregnancy body 
mass index (23, 25, 29, 30), in utero exposure to DES (23,30), a family history of 
hypertension (25), use of a barrier contraceptive (15), length of sexual cohabitation) 16), 
donor intrauterine insemination (17), chronic hypertension (risk ratio: 10:1) (31), diabetes 
mellitus (risk ratio: 2:1) (24), chronic renal disease (risk ratio: 20:1) (32), 
antiphospholipid syndrome (risk ratio: 10:1) (33) and angiotensinogen gene T235: 
homozygous (risk ratio 20:1) and heterozygous (risk ratio 4:1) (34). Those who live at 
high altitudes also have an increased incidence of preeclampsia when compared to those 
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living at sea level (35). Palmer et al believe that this finding is secondary to the 
interference of the high altitude with the normal vascular adjustments needed during 
pregnancy. They assert that this may be analogous to other conditions that also decrease 
uteroplacental oxygen delivery such as preeclampsia (35). Asthma during pregnancy has 
also been shown to increase the risk of preeclampsia suggesting that both preeclampsia 
and asthma might be caused by a third factor affecting vascular smooth muscle reactivity 
(OR: 2.52, 95% Cl: 1.47-4.35, p=0.0008) (36). Additionally, clinically normal patients 
with elevated mid-trimester levels of urine beta-core fragment of human chorionic 
gonadotropin are at increased risk for the subsequent development of preeclampsia (37). 
Controversy exists regarding the finding that African American race is a risk 
factor. Mittendorf et al established in a nested, case-control study that black race was 
positively associated with preeclampsia (OR: 1.5, 95% Cl; 1.1-1.9) while Savitz and 
Zhang found that in their study population, blacks and whites had similar risks of disease 
(22, 23). 
Other behaviors and factors are protective against the development of 
preeclampsia. Cigarette smoking appears to have a protective effect in the development 
of preeclampsia (22, 23, 38, 39). Klonoff- Cohen et al. conducted a case-control study 
comparing the smoking histories of 110 nulliparous preeclamptic women and 115 healthy 
nulliparous women aged 15-35 years delivering at North Carolina Memorial Hospital 
(39). They found that after adjustment for work during pregnancy, alcohol use, 
medication use, contraceptive choices and family history of preeclampsia there was a 
negative association between cigarette smoking during pregnancy and preeclampsia (OR: 
0.71, 95% Cl: 0.33-1.50) (39). In another case- control study, Mittendorf et al also found 
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a negative association between cigarette use and preeclampsia after multiple logistic 
regression analysis (OR: 0.6, 95% Cl: 0.5-0.8) (23). A history of spontaneous abortions 
also appears to be protective in multiparous women (OR: 0.09, 95% Cl: 0.02-0.48) (25). 
Just as there are contradictory findings regarding the risk factors for preeclampsia, 
even greater disagreement exists regarding the finding that adolescents are at an increased 
risk for the development of preeclampsia. Many studies have found that mothers with a 
young maternal age are at increased risk for developing preeclampsia (6, 40-44). Other 
studies, however, report that there is no increase in the risk of preeclampsia associated 
with young maternal age, and there may even be an increase in risk as the maternal age 
increases (45-52). Despite this controversy surrounding the specific risk of developing 
preeclampsia for adolescents, there are very few studies focusing only on the adolescent 
population and any unique qualities that may predispose this group to develop 
preeclampsia. Since approximately one million teenagers become pregnant in the United 
States each year, it is important to gain a better understanding of the specific risk factors 
associated with the development of preeclampsia in an adolescent population in order to 
improve our ability to predict who is at risk for developing preeclampsia and provide 
better preventive strategies (53). The following retrospective cohort study, therefore, 
aims to evaluate risk factors associated with the subsequent development of preeclampsia 
in adolescents. 
Statement of Purpose: 
The present retrospective cohort study seeks to identify the risk factors associated 
with the development of preeclampsia in adolescents. The aim is to use this information 
to improve the current understanding of the etiology and pathogenesis of this disorder 
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and facilitate identification of adolescent patients at risk for the development of 
preeclampsia. 
Materials and Methods: 
Subjects were selected from all patients who delivered a live singleton at Yale- 
New Haven Hospital during the time period between January 1, 1994 and April 26, 1997. 
Patients with pre-existing renal disease, chronic hypertension, diabetes mellitus, a 
pregnancy facilitated by in vitro fertilization, a multiple gestation or age over eighteen 
years were excluded from our study. Only patients receiving prenatal care in the Yale 
University Women’s Center, the Hill Health Center and Community Health Care Plan 
were included. 
A standard form devised by the investigators was used to abstract information 
from the 435 charts that fit the criteria specified above (Appendix A). The Human 
Investigation Committee of the Yale University School of Medicine authorized the 
review of charts (Protocol # 9052; Appendix B). Maternal demographic information 
included age, race, marital status, employment status, type of insurance, clinic service 
and whether level of education was age appropriate. Information on personal habits 
included cigarette use, alcohol use and use of illicit drugs. Data abstracted regarding past 
and present medical and obstetric history included gravidity, parity, age at menarche, 
gynecologic age, pre-pregnancy height and weight, pre-pregnancy body mass index, 
weight gain during pregnancy, gestational age at first visit, number of prenatal visits, 
gestational age at delivery, gestational diabetes during pregnancy, one hour GCT test 
results, HIV status if known, positive culture for Group B Streptococcus during 
pregnancy, hyperemesis gravidarum during this pregnancy, sexually transmitted diseases 
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diagnosed during this and prior pregnancies, history of induced or spontaneous abortions, 
urinary tract infections during this pregnancy, maximum biood pressure recorded during 
each trimester of this pregnancy and presence of preeclampsia during prior or current 
pregnancy. Neonatal data included birth weight, gestational age at delivery, incidence of 
low birth weight and preterm births, and neonatal morbidity and mortality. 
Pre-pregnancy body mass index was calculated using the Quetelet index (weight 
(kg)/ meters2) incorporating the pre-pregnancy weight reported by the patient during the 
first prenatal visit and the height measured and recorded at the first prenatal visit. 
Gynecologic age was defined as chronological age at conception minus the patient’s age 
at menarche (54). A diagnosis of preeclampsia was given if patients had two blood 
pressure measurements taken after twenty weeks gestational age and obtained at least six 
hours apart that were > 140 mmHg systolic or > 90 mmHg diastolic. Additionally, in 
order to receive the diagnosis of preeclampsia patients had to have at least two urine 
dipstick measurements obtained at least six hours apart with greater than or equal to 2+ 
protein. Patients were further classified as having severe preeclampsia if they met any of 
the following criteria: systolic blood pressure > 160 mmHg or diastolic blood pressure 
>110 mmHg, proteinuria > 5g/ 24 hours, elevated serum creatinine, grand mal seizures, 
pulmonary edema, oliguria < 500ml/24 hours, microangiopathic hemolysis, 
thrombocytopenia, hepatocellular dysfunction, intrauterine growth retardation or 
oligohydramnios, or headache, visual disturbances, epigastric or right-upper quadrant 
pain (55). 
In the univariate analysis, categorical variables were tested with the chi square or 
Fisher exact test and continuous variables with two-tailed Student t test. Statistical 
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significance was defined as a P value < 0.05. Multiple logistic regression analysis was 
then used to determine whether the factors found to be statistically significant by 
univariate analysis remained significant after controlling for potentially confounding 
variables. Data was expressed as odds ratios with 95% confidence intervals. All 
statistical analyses were performed using StatView 5.0 for Power Macintosh. 
Results: 
Part I: 
During the time period between January 1, 1994 and April 26, 1997, 435 women 
eighteen years or younger who fit the above specified criteria delivered at Yale-New 
Haven Hospital. Table 1 presents the maternal demographic characteristics of these 
women. 
The average chronologic age of the population was 16.2 years with a standard 
deviation of 1.4 and a standard error of 0.07. Our study population was 60.2% African 
American, 20.5% Hispanic and 19.3% Caucasian. Ninety-seven percent of this 
population was unmarried while the remaining three percent were married. 70.8% of 
these adolescents were unemployed. 80.7% of these young mothers received Medicaid as 
their insurance. 87.4% of the population who delivered at Yale-New Haven Hospital 
during this time period also received their prenatal care in the Women’s Center. The 
remaining 9.2% and 1.8% of our population received their prenatal care at the Hill Health 
Center and Community Health Care Plan respectively. Information regarding where the 
subject received her prenatal care was not available for eleven of the four hundred and 
thirty-five charts (1.6 %). 55.6% of this study population had an age appropriate 
education level. 

Table 1 Maternal Demographic Characteristics 
Maternal Demographic Characteristics Number Percent (%) 
Average Chronologic Age 16.2 years Not applicable 
Race 
African American 262/435 60.2 
Hispanic 89/435 20.5 
Caucasian 84/435 19.3 
Marital Status 
Single 422/435 97 
Married 13/435 3 
Employment Status 
Unemployed 308/435 70.8 
Medicaid 351/435 80.7 
Prenatal Clinic Site 
Yale University Women’s Center 380/435 87.4 
Hill Health Center 40/435 9.2 
CHCP 8/435 1.8 
Level of Education Age Appropriate 242/435 55.6 
CHCP-Community Health Care Plan 
Table 2 presents the pertinent medical history data from our population. The 
average pre-pregnancy height of our population was 64.0 inches with a standard 
deviation of 2.5 and a standard error of 0.1. Information on pre-pregnancy height for 
forty-four of the 435 subjects was not found in the corresponding charts. The average 
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pre-pregnancy weight of the subjects was 134.4 pounds with a standard deviation of 29.0 
and a standard error of 1.5. Information on pre-pregnancy weight was not available for 
fifty-three subjects. The average pre-pregnancy body mass index (BMI) was calculated 
to be 23 kg/m2 with a standard deviation of 4.63. The pre-pregnancy BMI was not 
calculated for sixty-four subjects given the corresponding lack of either pre-pregnancy 
height or pre-pregnancy weight. 
Table 2 Selected Maternal Medical Characteristics 
Medical Characteristic Value Standard Standard 
Deviation Error 
Average Pre-Pregnancy Height 64.0A 2.5 0.1 
Average Pre-Pregnancy 134.4b 29.0 1.5 
Weight 
Average Pre-Pregnancy BMI 23 c 4.63 
BMI- Body Mass Index 
Expressed in inches 
expressed in pounds 
expressed in kg/m 
The information regarding past and present obstetric history is shown in Table 3. 
69.9% of the population was nulliparous. The average age at menarche of the study 
group was 11.8 years with a standard deviation of 1.47 and a standard error of 0.07. The 
minimum age at menarche was eight years old and the maximum age was seventeen 
years old. The average gynecologic age (GA) was 4.39 years with a standard deviation 
of 1.79 and a standard error of 0.09 with a maximum age of 9 years. The average weight 
gain during pregnancy was 27.05 pounds with a standard deviation of 13.48 and a 
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standard error of 0.71. The average weight gain per week was 1.18 pounds with a 
standard deviation of 0.53 and a standard error of 0.03. The average gestational age at 
the first prenatal visit was 14.49 weeks with a standard deviation of 7.17 and standard 
error of 0.36. The average number of prenatal visits was 9.70 with a standard deviation of 
4.0 and a standard error of 0.20. 
Table 3 Selected Maternal Obstetric Characteristics 
Obstetric 
Characteristic 
Value Standard 
Deviation 
Standard Error 
Nulliparous 69.9% Not applicable Not applicable 
Average age at 
Menarche (years) 
11.80 1.47 0.07 
Average GA (years) 4.39 1.79 0.09 
Average weight 
gain during 
pregnancy (lbs) 
27.05 13.48 0.71 
Average weight 
gain per week (lbs) 
1.18 0.53 0.03 
Average gestational 
age at first prenatal 
visit (weeks) 
14 .49 7.17 0.36 
Average number of 
prenatal visits 
9.70 4.00 0.20 
GA = Gynecologic Age 
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Many women in our study experienced complications of pregnancy as seen in 
Table 4. Two women (0.5%) developed gestational diabetes. Twenty-one women 
(4.8%) had positive cultures for Group B Streptococcus (GBS) during pregnancy. Forty- 
five women (10.3%) had at least one sexually transmitted disease (STD) diagnosed 
during this pregnancy. Eighty-one women (18.6%) had and received treatment for a 
urinary tract infection (UTI) during this pregnancy. Fifty-six women fit the criteria 
previously cited for preeclampsia during this pregnancy. Our incidence of preeclampsia 
in this population was 12.9%. 
Table 4 Complications During Pregnancy 
Complication Number Percent (%) 
Gestational Diabetes 2/435 0.5 
Positive Culture for GBS 21/435 4.8 
Sexually Transmitted Disease 45/435 10.3 
Urinary Tract Infection 81/435 18.6 
Preeclampsia 56/435 12.9 
Univariate statistical analysis with contingency table (chi square and Fisher 
exact tests) or the Student t test as appropriate revealed that gynecologic age (GA), 
chronologic age (CA), pre-pregnancy BMI, UTI, the total weight gain during pregnancy, 
the pounds gained per week of pregnancy and pre-pregnancy weight were statistically 
significant risk factors for the development of preeclampsia in adolescents during 
pregnancy. Gynecologic age and chronologic age have a negative correlation with the 
development of preeclampsia. Pre-pregnancy BMI, UTI, total weight gain during 
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pregnancy, weight gain per week of pregnancy and pre-pregnancy weight were all 
positively correlated with preeclampsia in adolescents. Table 5 reveals the specific Odds 
Ratio (OR), 95% Confidence Interval (Cl) and p value for each variable after analysis by 
simple logistic regression. 
Table 5 Significant Risk Factors after Simple Logistic Regression 
Risk Factor Odds Ratio 95% Cl P value 
GA 0.82 0.69-0.96 0.02 
CA 0.81 0.67-0.99 0.04 
Pre-Pregnancy BMI 1.11 1.05-1.17 0.0003 
UTI 2.00 1.03-3.89 0.04 
Total Weight Gain 1.046 1.02-1.07 0.0001 
During Pregnancy 
Weight Gain per 2.40 1.42-4.06 0.001 
Week of Pregnancy 
Pre-Pregnancy 1.01 1.01-1.02 0.0008 
Weight 
GA- Gynecologic Age CA- Chronologic Age 
UTI- Urinary Tract Infection BMI- Body Mass Index 
After adjustment for significant factors, multiple logistic regression analysis 
revealed that gynecologic age, pre-pregnancy BMI, weight gain per week of pregnancy 
and the total weight gain during pregnancy remained significant for the development of 
preeclampsia. The specific adjusted odds ratio and 95% confidence interval for each 
variable is expressed in Table 6 below. Chronologic age and incidence of UTI during 
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pregnancy were no longer significant after adjustment for significant factors with 
multivariate logistic regression analysis. 
Table 6 Statistical Significance after Multivariate Logistic Regression Analysis 
Characteristic Adjusted Odds 95 % Cl P value 
Ratio 
Gynecologic Age 0.81 0.67 - 0.99 0.04 
Pre-Pregnancy BMI 1.10 1.03 -1.18 0.01 
Pre-Pregnancy 1.01 1.00- 1.02 0.01 
Weight 
Weight gain per 2.19 1.27 - 3.76 0.004 
week of pregnancy 
Total weight gain 1.04 1.02-1.06 0.001 
Although both the amount of weight gained per week of pregnancy and the total 
weight gain during pregnancy remained significant after multivariate logistic regression 
analysis, we feel that the weight gained per week is a more accurate measure than the 
total weight gain. This increased accuracy is due to the finding that women with 
preeclampsia will have a higher weight gain during pregnancy than those without 
preeclampsia. Subsequently, these same individuals with the greater total weight gain 
will often deliver earlier than normal controls secondary to the complications of 
preeclampsia, thus making the total weight gain not clinically significant and less 
reliable. 
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Part II: 
After finding that a high pre-pregnancy BMI was positively associated with an 
increased risk for the development of preeclampsia in adolescent pregnancies, we 
attempted to further subcategorize pre-pregnancy BMI in order to determine if a specific 
pre-pregnancy BMI was either protective against or predisposed an adolescent to the 
development of preeclampsia. The study population was the same as that described in 
the materials and methods section above. The sub-categorization of BMI, as defined by 
Cnattingius et al, divides subjects into four distinct groups based on BMI as seen in Table 
7 below. 
Table 7 Classification by Pre-Pregnancy Body Mass Index 
Classification Body Mass Index Range15 
Underweight/Lean <20.0 
Normal weight^ 20.0-24.9 
Overweight 25.0-29.9 
Obese >30.0 
A Cnattingius, S, Bergstrom, R, Lipworth, L, Kramer, MS. Prepregnancy weight and the 
risk of adverse pregnancy outcomes. N Engl J Med 1998; 338:147-52. 
i) . . 1 
Body mass index is expressed in kg/m“ 
( This group will be used as the reference group in further analyses. 
Simple logistic regression analysis revealed that obese adolescents had a 
significantly higher risk for the development of preeclampsia when compared to those 
with a normal pre-pregnancy body mass index (OR: 4.4, 95% Cl: 1.8-10.9, p = 0.001). 
The incidences of preeclampsia in women categorized as underweight, normal weight. 

overweight and obese were 9.2%, 11.1%, 19.0% and 35.7%. Table 8 presents the crude 
odds ratio, 95% confidence interval and p value for each subcategory. 
Table 8 Simple logistic regression analysis of pre-pregnancy BMI for underweight, 
overweight, and obese adolescents when compared to normal weight adolescents for 
risk of preeclampsia 
Category Number Percent (%) Odds Ratio 95% Cl P Value 
Normal 188 50.0 1.0 Referent 
weight 
Underweight 98 26.1 0.81 0.36-1.84 0.61 
Overweight 63 16.8 1.88 0.87-4.09 0.11 
Obese 27 7.2 4.44 1.81-10.9 0.001 
After adjustment for statistically significant factors with multiple logistic 
regression analysis, the risk of developing preeclampsia with a pre-pregnancy BMI >30 
kg/m2 remained significant (adjusted OR: 4.54, 95% Cl: 1.46 - 14.14, p = 0.009) while 
being underweight or overweight remained insignificant. Adolescents with a pre¬ 
pregnancy BMI > 30 kg/m2 have a four-fold increased risk of developing preeclampsia 
during pregnancy. Additionally, when the underweight and overweight adolescents were 
compared to the normal weight adolescents, there was no significant increase in the risk 
of developing preeclampsia nor was there any protective effect of being underweight. 
Table 9 below shows the adjusted odds ratio, 95% Cl and p value for each subcategory 
after multiple logistic regression analysis. 
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Table 9 Multiple Logistic Regression Analysis of pre-pregnancy BMI for 
underweight, overweight, and obese adolescents when compared to normal weight 
adolescents for risk of preeclampsia 
Category Number Percent (%) Adjusted 
Odds Ratio 
95% Cl P Value 
Normal 
Weight 
188 50.0 1.0 Referent 
Underweight 98 26.1 0.83 0.35-1.96 0.67 
Overweight 63 16.8 1.83 0.78-4.29 0.16 
Obese 27 7.2 4.54 1.46-14.14 0.009 
Part III: 
Since simple logistic regression analysis revealed that gynecologic and 
chronologic age were statistically significant risk factors for preeclampsia in adolescent 
pregnancy, we attempted to determine which specific gynecologic and chronologic ages 
put an adolescent at greater risk for the development of preeclampsia. Our initial 
findings revealed that only gynecologic age remained statistically significant after 
analysis with multivariate logistic regression. It was felt that the wide range of ages in 
the chronologic age category, with fewer subjects at the lower end of the range, was 
confounding to make the entire group less statistically significant. We, therefore, aimed 
to isolate which age groups were at a higher risk for the development of preeclampsia. 
The same study group as previously mentioned in the materials and methods 
section was used. The information was abstracted from the appropriate charts using the 
questionnaire in Appendix A. 
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Groups of individuals with a gynecologic age and chronologic age below specific 
cutoff values were analyzed using simple logistic regression analysis. A gynecologic age 
less than 5 or 4 years was found to be a more specific cutoff value for identifying 
individuals with a statistically significant risk of developing preeclampsia (OR: 1.83, 
95% Cl 1.02-3.31, p = 0.04). Additionally, individuals with a chronologic age less than 
17 or 16 years was a statistically significant cutoff value for the development of 
preeclampsia in adolescents (OR: 1.99, 95% Cl: 1.10-3.62, p = 0.02). Table 10 shows 
these results. 
Table 10 Statistical Significance of Selected Gynecologic and Chronologic Ages by 
Simple Logistic Regression Analysis 
Variable' Odds Ratio 95% Cl F* value 
GA < 5 1.84 1.02 - 3.31 0.04 
GA < 4 2.12 1.20 - 3.75 0.01 
CA< 17 1.99 1.10 - 3.62 0.02 
CA < 16 1.93 1.08 - 3.47 0.03 
A Gynecologic Age (GA) and Chronologic Age (CA) are expressed in years 
After adjustment for significant factors, analysis with multiple logistic regression 
revealed that a gynecologic age less than four years, chronologic age less than seventeen 
years and a chronologic age less than sixteen years all remained significant risk factors 
for developing preeclampsia during adolescent pregnancy. Furthermore, the cumulative 
effect of analyzing gynecologic age with chronologic age increased the strength of the 
association and the risk for developing preeclampsia. Those individuals with a 
gynecologic age less than four years and a chronologic age less than seventeen years 
appear to be at the greatest risk for developing preeclampsia, (adjusted OR: 3.27, 95% 
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Cl: 1.627 - 6.552, p= 0.0009) as shown in table 11 below. Although an individual with a 
chronologic age less than seventeen years or less than sixteen years appears to be at 
increased risk for the development of preeclampsia, chronologic age less than seventeen 
years was felt to be a more accurate predictor of preeclampsia as it is more inclusive. 
Table 11 Statistical Significance of Gynecologic and Chronologic Ages by Multiple 
Logistic Regression Analysis 
Variable^ Adjusted Odds 
Ratio 
95 % Cl P Value 
GA < 4 2.22 1.121 -4.407 0.02 
CA< 17 2.85 1.374- 5.889 0.005 
CA< 16 2.06 1.039-4.074 0.039 
GA < 5 and CA < 
16 
2.60 1.294-5.203 0.007 
GA < 4 and CA < 
16 
2.72 1.287-5.741 0.009 
GA < 5 and CA < 
17 
2.86 1.452 - 5.638 0.002 
GA< 4 and CA < 17 3.27 1.627 - 6.552 0.0009 
AGynecologic Age (GA) and Chronologic Age (CA) are expressed as years 
In summary, our study found that individuals with a pre-pregnancy body mass 
index greater than 30kg/m“, the individual's pre-pregnancy weight, the amount of weight 
one gains per week during pregnancy, a chronologic age less than seventeen years, a 
gynecologic age less than four years, a gynecologic age less than five years in addition to 
a chronologic age less than sixteen or seventeen years, and a gynecologic age less than 
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four years in addition to a chronologic age less than sixteen or seventeen years are each 
significant risk factors for developing preeclampsia during pregnancy. 
Discussion: 
Our retrospective cohort study found that adolescents with a pre-pregnancy body 
mass index > 30 kg/nr were 4.5 times more likely to develop preeclampsia during 
pregnancy than those adolescents with a pre-pregnancy body mass index in the “normal” 
range of 20.0 kg/m - 24.9 kg/m . This finding confirms prior studies that showed an 
association between elevated body mass index and preeclampsia (23, 25, 29,56-59). In 
these investigations, body mass index is used as a measure of relative obesity. 
Obesity is characterized by expanded blood volume and increased cardiac output 
(60). Additionally, excess weight increases the body’s oxygen consumption, leading to 
an increase in stroke volume and cardiac output in an effort to meet the increased 
metabolic demands. Hypertension likely results when the systemic vascular resistance 
fails to decrease as cardiac output increases (60). In the context of this pre-existing 
physiology in obese individuals, pregnancy increases cardiac output above this already 
elevated baseline (56). Stone et al postulate that obese individuals may already be 
maximally vasodilated early in pregnancy and are unable to compensate for the additional 
increase in cardiac output resulting from pregnancy (56). While the body attempts to 
sustain the increased blood flow, hypertension may develop and exacerbate the 
endothelial injury and lead to the clinical sequela of preeclampsia (56). 
Potter et al offer another explanation for the association between obesity and 
preeclampsia (61). Their research showed that patients who develop preeclampsia have 
increased levels of triglycerides when compared with controls (61). Endersen et al. also 
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revealed that the sera of preeclamptic patients have a higher ratio of free fatty acids to 
albumin and increased lipolytic activity when compared with the sera from 
uncomplicated pregnancies (62). Additionally, the sera from these preeclamptic women 
induced triglyceride accumulation in cultured endothelial cells with a reduction in 
prostacyclin release. Wang J et al further showed that hyperlipidemic sera enhances 
endothelial lipid peroxide production (63). Wang Y et al described the endothelial cell 
damage that results from endothelial lipid peroxides and the subsequent vasoconstriction 
and platelet aggregation the lipid peroxides promote (64). Stone et al postulated that 
obesity-associated hyperlipidemia may directly or indirectly, through lipid peroxides, 
damage maternal endothelial cells (56). Endothelial cell damage may contribute to the 
severity of the preeclamptic process, thus explaining the association between obesity and 
preeclampsia (56). 
Prior studies have also subcategorized BMI in order to determine which 
individuals are at the greatest risk of developing preeclampsia. Sibai et al examined a 
cohort of healthy nulliparous women and found that the incidence of preeclampsia in this 
population was 7.6% (58). The investigators divided the population into four groups: 
BMI < 19.8 kg/m2, BMI 19.8 kg/m2 - 25.9 kg/rn2, BMI 26 kg/m2 - 34.9 kg/m2 and BMI > 
35.0 kg/m . An increased incidence of preeclampsia was associated with an increase in 
BMI as evidenced by an incidence of 4.3% in the group with BMI <19.8 kg/m2 and an 
incidence of 12.6% in the group with a BMI of > 35 kg/rn". When these two extreme 
groups were compared, the odds ratio was 3.22 for those with BMI >35 kg/m" versus 
those with BMI <19.8 kg/m", suggesting that individuals with a BMI >35 were at least 
three times more likely to develop preeclampsia than those with a BMI < 19.8 (58). Von 
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Stallie et al also conducted a retrospective case-control study of severe preeclampsia (65). 
They defined severe obesity as a BMI > 32.3 kg/m2 and found that a BMI > 32.3 kg/m2 
was positively associated with preeclampsia, (OR: 3.5, 95% Cl: 1.68 - 7.46). Individuals 
considered to have severe obesity by this definition were three times more likely to 
develop preeclampsia than those with a BMI < 32.3 kg/m2 (65). 
Wolfe et al also found that a maternal body mass index greater than the 90th 
percentile for the individual was predictive of preeclampsia (OR: 2.26, 95% Cl: 1.71- 
2.99) (59). Interestingly, they noted that pre-pregnancy maternal weight was as 
predictive of preeclampsia as pre-pregnancy BMI. This finding led this research group 
to assert that there is no additional advantage to calculating maternal BMI instead of 
simply weighing the patient. Our study confirms this finding since both pre-pregnancy 
weight and pre-pregnancy BMI were both positively associated with preeclampsia (OR 
1.01, 95% Cl 1.00-1.02 and OR: 4.44, Cl: 1.03-1.18 respectively). Sibai et al also agreed 
with this finding in their study that evaluated 2947 healthy women with a single fetus 
(57). These women were prospectively followed from randomization at 13-27 weeks 
gestation through delivery. Half of these women were given low dose aspirin while the 
remainder received placebo. These investigators measured the relative pre-pregnancy 
weight, calculated as a percentage of desired weight for height, of these subjects. The 
relative pre-pregnancy weight was predictive of preeclampsia with a p value of <0.01 
(57). 
Mittendorf also reported that a pre-pregnancy BMI > 30 kg/m" was associated 
with preeclampsia (OR: 2.7, 95% Cl: 1.6-4.4) (23). Chesley et al also found that severe 
obesity is a risk factor for the development of preeclampsia; yet, he stated that this 
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finding was present secondary to the confounding presence of chronic hypertension in his 
population (66). Since our study excluded all patients with pre-existing chronic 
hypertension, chronic hypertension is not a confounding factor in our study. Cnattingius 
et al reported that the rate of preeclampsia among nulliparous women increased as body 
mass index increased: the incidence of preeclampsia was 2.8% in lean women and 10.2% 
in obese women (67). In this study, it appears that being in the underweight category was 
actually protective against the development of preeclampsia. Although our study used 
the same categories and values for underweight and obese women as Cnattingius et al., 
we did not find that women in the underweight category were protected against 
preeclampsia. 
Our current study differs from previous studies since we evaluated the risk of 
increased pre-pregnancy BMI in women eighteen years old or younger. These previously 
mentioned studies evaluated the influence of pre-pregnancy BMI on the risk of 
preeclampsia in the general population, thus making no distinction between adolescents 
and adults in the analysis. Additionally, previous studies have examined BMI as a risk 
factor for adverse pregnancy outcomes such as early and late fetal death, preterm 
delivery, and growth retardation instead of preeclampsia alone (67). Our study, however, 
does have several limitations associated to our finding that high BMI is positively 
associated with preeclampsia. For example, pre-pregnancy weight was abstracted from 
the charts where it was initially obtained by patient report at the first prenatal visit. The 
patients self reported their pre-pregnancy weight and so it is subject to recall bias. Pre¬ 
pregnancy weight was used as an individual variable as well as part of the calculation for 
pre-pregnancy BMI, therefore subjecting pre-pregnancy BMI to this same recall bias. 

26 
Additionally, our subjects were not divided into nulliparous and multiparous groups for 
purposes of analysis nor were they analyzed within racial groups. 
In addition to finding an association between elevated pre-pregnancy BMI and 
preeclampsia in adolescents, this study also found a strong association between low 
gynecologic and/or low chronologic age and the risk of developing preeclampsia. As 
mentioned previously, this finding confirms many existing studies (40-44). Leppert et al 
looked at the effect of maternal age on various birth outcomes (41). They noted that in a 
group of 529 women aged 13-19 years there was a 6.6% incidence of preeclampsia while 
there was an incidence of 2.6% in the 20-36 year old age group. Teenagers, therefore, 
appear to be twice as likely to experience preeclampsia than women older than twenty 
years of age (41). In a retrospective study comparing the pregnancy performance of 471 
primigravid patients less than 15 years old with a control group of 471 primigravids 
between 19-25 years old, Duenhoelter et al found that 34.2 % of the women less than 15 
years of age developed preeclampsia whereas only 25.3% of the women in the older age 
group did (p<0.01) (40). This study further supports the finding that younger mothers, 
more specifically adolescents, are at increased risk for preeclampsia. Using information 
from the National Hospital Discharge survey conducted by the National Center for Health 
Statistics from 1979-1986, Saflas et al also noted that women less than 15 years old had a 
2.8 fold higher risk of developing preeclampsia than women between 30-40 years of 
age (5). In another retrospective case-control study, 9.9 % of the adolescents developed 
preeclampsia while only 4% of the women aged 20-30 years did giving a p value of 
<0.001 (42). Clark et al also looked at preeclampsia in adolescents and noted that 22.3%, 
developed preeclampsia (6). They then found that although prenatal care helped decrease 
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the incidence of preeclampsia from 22.3% to 11-13 % the incidence still remained high 
(6). Satin et al. established that pregnant adolescents, younger than 17 years, had an 
increased incidence of medical complications for both the mother and the fetus when 
compared with older mothers (43). Additionally, the risks may be the greatest for the 
youngest teenagers. 
Although our study and the previously mentioned studies have shown evidence 
that adolescents are at higher risk for preeclampsia than the general population, many 
studies contradict this finding. For example, Berenson et al showed that there was not a 
significant difference between the development of preeclampsia in pregnant women 12- 
15 years old (9%) when compared to 16-17 year olds (9%) and 20-22 year olds (10%) 
(45). They therefore concluded that young maternal age was not a risk factor for 
preeclampsia (45). In this study, there were 147 nulliparous women in the group of 12- 
15 year olds and nearly twice as many in the 16-17 year old group (45). This discrepancy 
in the number of subjects in each group is most likely secondary to the smaller number of 
women who deliver babies at an age less than 15 years. Given the small sample size in 
the study population there may not have been adequate statistical power to detect a true 
statistical difference in this population when compared to those aged 16-17 and those 20- 
22 years old. Additionally, the patients in this study participated in specialized 
adolescent programs that may have improved their prenatal care and thus helped decrease 
the risk of preeclampsia. 
Poma et al also did not find a significant difference in the incidence of 
preeclampsia between primigravids <16 years old (14.6%) and primigravids greater than 
20 years old (11.3%) (46). Hoff et al compared women 12-16.99 years old with women 
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17-31 years old by race and found that there was not a significant difference between 
adolescents and adults when compared within the same race (47). Other studies have 
also shown that there is not a significant difference between the incidence of 
preeclampsia in adolescents when compared to adults (48, 50-52). In the study 
conducted by Osbourne et al, the investigators did not attempt to differentiate between 
preeclampsia and other forms of hypertension (52). Felice et al. examined the correlation 
between both the chronologic and gynecologic age and the frequency of preeclampsia 
and did not find that those with a lower chronologic or gynecologic age were at increased 
risk (49). 
These discrepancies regarding whether adolescents are at increased risk of 
preeclampsia likely results from differences in patient population, clinical care, or 
methodologies. For example, these studies do not all use the same criteria for diagnosis 
of preeclampsia. Felice et al define preeclampsia as a blood pressure greater than 140/90 
or an increase in either systolic pressure by 20 mmHg or diastolic pressure by 15 nimHg 
(49). Bozkaya et al define preeclampsia as two blood pressure readings greater than 90 
mmHg measured twenty-four hours apart (42). Still other studies do not specify the 
criteria they used for defining preeclampsia (6, 40, 46). 
In addition to the lack of a uniform definition of preeclampsia in these studies, 
there is not a consistent definition of young maternal age. Some studies define young 
maternal age as individuals less than fifteen years old (5, 40, 45) while other studies 
consider all individuals under nineteen to be of young maternal age (41). Regardless of 
what age limit researchers choose for their studies, there is no clear definition explaining 
why each age was chosen as the upper limit of young maternal age. 
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At this time it is unclear how biologic immaturity may influence the risk of 
preeclampsia. One possible explanation may be that the uterine vasculature is less well 
developed in young women conceiving closer to menarche than in those with a higher 
gynecologic age or further from menarche. Another possibility is that the uterus may 
need repeated exposure to ovarian hormones, i.e. a specific number of cycles before 
conception. Until it is clearer how biologic immaturity influences the risk of 
preeclampsia, gynecologic age may represent a more accurate measure of a woman’s 
biologic readiness for pregnancy than her chronologic age alone. 
The results from our study also revealed that there was a positive association 
between the amount of weight gained per week of pregnancy and the risk of developing 
preeclampsia. As was previously mentioned, we feel that the weight gain per week of 
pregnancy is a more sensitive and reliable risk factor to predict the development of 
preeclampsia. Our finding of an association between the amount of weight gained during 
pregnancy and the risk of developing preeclampsia confirms other studies (68-72). Over 
a decade ago here at Yale, Shepard et al studied maternal weight gain as a proportion of 
prepregnant weight to examine its relationship to complications experienced during 
pregnancy, labor and delivery for healthy women. Women in this study did not have 
preexisting chronic disease, were within their normal prepregnant weight for height and 
delivered single infants without any congenital malformations between 37 to 42 weeks 
(68). Their population included women aged 14 years and older. 11.6% of their study 
population was 14-20 years old and the incidence of preeclampsia in their total 
population was 3.6% (68). Shepard et al found that women with a proportional weight 
gain greater than 35% had a fourfold risk of becoming preeclamptic when compared to 
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women with weight gains in the range of 16% - 25% (relative risk =4.01,95%CI: 1.69- 
9.51) (68). They recommend that evaluating maternal weight gain in terms of a 
proportion of prepregnant weight will be a better predictor of preeclampsia and other 
complications of pregnancy than absolute maternal weight gain. 
Building on the findings of Shepard et al and others (68-72) who showed a linear 
relationship between weight gain and the development of preeclampsia, Theron and 
Thompson attempted to use centile charts to screen for pregnancy complications. Their 
goal was to improve the tools available to the clinician when evaluating an individual’s 
risk, based on her weight gain, for developing preeclampsia based (70). Theron and 
Thompson examined 1003 women with a singleton pregnancy for an association between 
weight gain and pregnancy complications (70). They measured weight gain as the 
average weight gain per week over the entire record. Weight gain was then divided into 
four categories of equal frequency: < 0.33kg/week, > 0.33kg/week and <0.45 kg/week, 
>0.45kg/week and <0.56kg/week, >0.56kg/week. The mean age of the women in the 
study was 25.2 years (range 14-43 years). The incidence of preeclampsia in their 
population was 7.3% (73/1003) (70). Although the incidence of preeclampsia increased 
with increasing weight gain, Theron and Thompson found that excessive weight gain is 
not an effective screening procedure for preeclampsia (70). A previous study by Redman 
also confirms this finding (71). 
A subsequent study by Theron and Thompson, examining the usefulness of 
adaptive centiles for weight gain and sudden weight gain spurts in identifying those who 
will develop preeclampsia, confirmed their earlier finding of an association between 
preeclampsia and increased weight gain (72). In this study, Theron and Thompson 
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examined the usefulness of a sudden weight gain spurt as a predictor of preeclampsia. 
They concluded that a sudden weight gain spurt, defined as crossing centile bounds or 
>0.9kg per week weight gain, is not a reliable sign of impending preeclampsia (72). 
Although there appears to be an association between excessive weight gain and 
preeclampsia, the usefulness of excessive weight gain to identify women who will 
develop preeclampsia during pregnancy is often questioned. It is unlikely that the weight 
gain itself causes the preeclampsia. Additionally, it is difficult to determine if the 
preeclampsia was preceded by sudden or gradual weight gain. Also, it is unclear if the 
weight gain is actually fluid retention. If the weight gain is a marker of fluid retention 
then this weight gain would be a result of preeclampsia itself and not a cause of it. In 
order to be a useful screening tool, weight gain must antedate a rise in diastolic blood 
pressure or the development of proteinuria. Additionally, as Chesley noted in his earlier 
work, a sudden weight gain may be obscured unless observed over one or two weekly 
periods (69). Since many pregnant adolescents have poor attendance in prenatal clinics, 
leading to greater time periods between appointments, a sudden weight gain may be 
missed. Currently, an effective means for incorporating weight gain as a screening 
modality with a reasonable sensitivity and specificity does not exist. Until centiles for 
weight gain with good sensitivity and specificity are developed, weight gain will remain 
ineffective as a screening tool. 
Although previous studies have found that UTI during pregnancy may place an 
individual at greater risk for preeclampsia, in our study, UTI did not remain significant 
after multiple logistic regression analysis (23,73,74). Hsu et al, however, did report that 
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the women in their study who received magnesium sulfate had urinary catheterization, a 
known risk factor for UTI, which may have been a possible confounding factor (73). 
In summary, our study revealed that obesity prior to pregnancy, the amount of 
weight gain per week of pregnancy, and biologic youth, as defined by low gynecologic 
and chronologic age, are strong risk factors for the development of preeclampsia in 
adolescents. Since it appears that obesity prior to pregnancy is a strong risk factor for the 
development of preeclampsia in adolescent pregnancy, future research should focus on 
strategies to normalize BMI before pregnancy in an effort to reduce the frequency of 
preeclampsia. Future research should also investigate methods to incorporate weight gain 
per week of pregnancy into a useful clinical tool that can assess the risk of preeclampsia 
with improved sensitivity, specificity, and positive predictive value. Additionally, 
continued laboratory research is necessary to help determine the possible relationship 
between the pathophysiology of preeclampsia and biologic youth. More research is still 
needed to examine the possible association between urinary tract infections and 
preeclampsia. 
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Appendix A: Data Collection Form 
Zip Code_ 
Study #_ 
Age at LMP_ 
Menarche_ 
Gynecologic Age_ 
G_P_ 
Service:_[University Private CHCP/YHP HROB Hill] 
Date of admission:_/_/_ 
Date of deliver}':_/_/_ 
Date of discharge:_/_/_ 
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Prenatal Information 
Race:_[African-American Caucasian Hispanic ASian 
Other _(list)] 
Religion:_[None Catholic Protestant Jewish Budhhist Hindu Muslim 
Other _(list)] 
LMP: 
HDD: 
EDD by LMP date:_Yes _No 
Earliest Ultrasound:_._weeks 
P/T:_Yes _No 
Marital Status:_[Single SEparated Married Divorced Widowed ] If married, 
number of years in current marriage:_ 
Last grade completed:_[(13) for first year of college, etc.] 
Education age -appropriate:_Yes _No 
Employed:_Yes _No _Unknown 
Insurance: _(name) 
Contraceptive method as of LMP:_[None BCPs DepoProvera/Norplant 
Diaphragm Condoms IUD] 
Gestational age at first prenatal visit:_weeks 
Prenatal Visit Number:_ 
Prepregnancy weight:_lbs/kg (circle) 
1st visit height:_in/cm (circle) weight:_lbs/kg (circle) BMI: _ 
Weight at delivery:_Ibs/kg (circle) 
Weight gain over pregnancy:_lbs/kg (circle) over_weeks 
Smoker during pregnancy:_Yes _No _Unknown 
If yes, number of cigarettes per day:_If quit, at what gestation:_wks 
.Alcohol " " :_Yes _No Amount:_ 
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Drugs " " :_[None IV Heroin IV cocaine Powder cocaine 
Crack cocaine Marijuana Other List:_ ] 
Urine toxicology positive during this pregnancy:_Yes _No _Unknown 
[hist:_ ] 
Caffeine use during pregnancy:_Yes _No _Unknown Amount_oz/d 
Depression during pregnancy._Yes _N o 
Exercise during pregnancy:_Yes _No _Unknown Amount_min/d 
Meds in pregnancy:  
Prenatal Hct: 1st_(_/_ /_) last_(_/_/_) 
One-hour GCT: _(_/_/_) 
Blood Type:_[A B AB O] 
Rh: _[Negative Positive] 
PPD:_[Negative Positive Unknown] 
Triple Screen (leave blank if not available):_._MOM (.AFT) 
_._MOM (hCG) 
_._MOM (Estriol) 
Screen positive for:_Down Syndrome _NTD 
HepBsAg:_[Negative Positive] 
Rubella:_[Nonimmune Immune] 
RPR: _[Nonreactive Reactive] 
Blood pressures:_/_(first visit)_weeks 
_/_(1st trimester, highest) Highest SBP:_ 
_/_(2nd trimester, highest) Highest SBP:_ 
__/_(3rd trimester, highest) Highest SBP:_ 
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Bleeding during this pregnancy:_None First tri Second tri Third tri 
Hyperemsis gravidarum:_Yes _No 
Gestational Diabetes: _Yes _No 
Ultrasound EFVV <10th%ile:_Yes _No _Unknown 
STD during pregnancy (Circle any): Gonorrhea Chlamydia Trichomonas 
cOndyloma Herpes Syphilis] 
Bacterial vaginosis during pregnancy:_Yes _No 
Group B strep culture positive any time during current pregnancy' or delivery:_Yes 
HIV:_[Negative Positive not Tested] 
UTI:_Yes _No 
Multiple gestation:_Yes(number of fetuses_) _No 
Other antepartum complications:  
Number of antepartum admissions: 
Reasons: _ 
No 
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Past Obstetric History 
Number of previous induced/elective terminations of pregnancy:_ 
Number of previous first trimester miscarriages:_ 
Number of previous second trimester miscarriages:_ 
Years since last pregnancy:_ 
Breastfed: _Yes -_months _No 
Years of each birth (>24 weeks): 19_ 
19_ 
19_ 
19_ 
19_ 
History of previous pregnancy with:_[LBW PTD Stillbirth 
pReeclampsia/eclampsia Congenital anomaly Other List 
Past Medical History 
Preexisting diabetes:_Yes _No 
Preexisting or hypertension on 2 separate occasions less than 20 weeks:_Yes _N o 
Asthma:_Yes  No 
HIV:_Yes _No _Unknown 
Sickle Cell Disease:_Yes _No 
Hyperthyroidism: _Yes _No 
Renal disease:_Yes _No 
SLE:_Yes _No 
Antiphospholipid Syndrome:_Yes _No 
Operations:_Yes _No List:___ 
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History of Depression:_Yes _No 
Other Medical history:_Yes _No List: 
Medications: 
Family History/Relationship: _/_ 
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Labor & Delivery 
Gestational Age at delivery: _ _ (ld=_ _.14, 2d=_ _.29, 3d=__.43, 4d=__.57, 5d=__.71. 6d=__.86) 
Neonatal number:_ 
PIH: _None _Mild _Severe 
Superimposed on chronic hypertension:_Yes _N o 
Antepartum B/Ps: 
Highest SBP:_Highest DBP:_ 
Lowest SBP:_Lowest DBP:_ 
Proteinuria: 
Highest Dipstick:_Zero-trace _+1 _+2 _+3 _+4 
Highest 24hr protein:_gm 
Criteria for Severe PIH: 
SBP >160 mmHg:_Yes _No 
DBP>110 mmHg:_Yes _No 
Proteinuria >5g/24hr_Yes _No 
Elevated serum Cr:_Yes _No 
Eclampsia: _Yes _No 
Pulmonary edema:_Yes _No 
Oliguria <500ml/24hr:_Yes _No 
Thrombocytopenia (<100K):_Yes _No 
Elevated LFTs: _Yes _No 
HELLP: _Yes _No 
IUGR:_Yes _No 
Oligohydramnios: _Yes _No 
Cerebral disturbances:_Yes _No 
Visual disturbances: Yes _No 
Epigastric/RUQ pain: Yes  No 
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Therapy for preeclampsia:_MgSC4 _Dilantin _Phenobarbital _Hydralazine 
_Labetalol _Nifedipine _Aldomet _Other 
Days from diagnosis to delivery:_days 
Highest blood pressure in labor:_/_Highest SBP: 
Induction:_Yes  No Augmentation:_Yes _No 
If yes, reason:_[ Infection Tracing abnormality Preeclampsia 
prolonged Rupture of membranes Other List: __ 
None given(5)] 
Method(s) (circle any): PG gel Misoprostol Cervidil Laminaria Pitocin 
Epidural: _Yes  No 
Cesarean section: Yes _No 
If yes, indication (circle any):_[nonreassuring fetal Testing (tracing or pH) 
labor Arrest failed Instrument Elective Other List__] 
Vaginal delivery:_Spontaneous Forceps Vacuum 
Tracing Abnormalities:_[None persistent nonReactive persistent Late 
decelerations Bradycardia] 
Chorioamnionitis (fever/antibiotics/positive tap):_Yes _No 
Abruption (retroplacental clot at delivery):_Yes _No 
Confirmed by placental pathology:_Yes _No 
Stillbirth: _Yes _No 
Maternal mortality:  Yes _No 
Other complications in labor:  _ 
Apgars: _(1 min)_(5 min)_(10 min) 
Cord pH: _. _(a)_._(v)_not obtained (0) 
Postpartum Course 

41 
Highest blood pressure:_/_Highest SBP:_ 
Postpartum complication (circle any): [None Hemorrhage Fever Endometritis 
Depression Preeclampsia eClampsia Other List:_] 
Contraceptive choice(circle any): [None DepoProvera OCPs Progesterone-only pill 
NorpLant IUD Foam/condoms DiAphragm Other List:_ 
Neonatal Course 
Sex:_ [Male Female] 
Birth weight: _gm or_lbs _ 
Circle: AG A SG4. LGA 
Positive blood cultures:_Yes _No 
Morbidity: [Pneumonia RDS 
Hyperbilirubinemia Other 
Mortality: _Yes _No 
Congenital anomaly: Yes _No 
Length of hospital stay: _days 
Blood Type:_[A B AB 
Rh:_[Negative Positive 
Breastfeeding:_Yes _No 
SIDS: _Yes _No 
oz 
Organism: _ 
BFD NEC 
List: _ 
List: _ 
O] 
ivh 
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